Infectious Diseases

NACI advises deferral of second dose in patients who develop myocarditis or pericarditis following the first dose of an mRNA COVID-19 vaccine.

A study published in JAMA this week found that providing physicians with feedback about their antibiotic prescribing can enhance both patient outcomes and health system sustainability.

French study shows significant boost in antibodies after a third dose of Pfizer–BioNTech COVID-19 vaccine in more than 100 transplant recipients.

Advise patients that persistent COVID-19–related loss of smell has an excellent prognosis with nearly complete recovery after one year.

No clear association to date, but authorities are closely following emerging evidence.

Allergic contact dermatitis from topical drug products may be overlooked as a cause of pruritic eczematous eruptions.

Health Canada grants interim authorization to Roche’s casirivimab and imdevimab.